Login to Your Account



Qiagen Pays $28.5M Cash For Molecular Staging Technology

By Cormac Sheridan


Wednesday, September 29, 2004
Qiagen NV is paying $28.5 million in cash to acquire whole-genome amplification technology from Molecular Staging Inc. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription